Integrated Investment Consultants Lowers stake in Neogen Corporation (NEOG)

Neogen Corporation (NEOG) : Integrated Investment Consultants reduced its stake in Neogen Corporation by 1.89% during the most recent quarter end. The investment management company now holds a total of 1,300 shares of Neogen Corporation which is valued at $68,328 after selling 25 shares in Neogen Corporation , the firm said in a disclosure report filed with the SEC on Oct 14, 2016.Neogen Corporation makes up approximately 0.03% of Integrated Investment Consultants’s portfolio.

Other Hedge Funds, Including , Private Trust Co Na reduced its stake in NEOG by selling 824 shares or 1.86% in the most recent quarter. The Hedge Fund company now holds 43,514 shares of NEOG which is valued at $2,325,388. Neogen Corporation makes up approx 0.58% of Private Trust Co Na’s portfolio.Capstone Asset Management Co reduced its stake in NEOG by selling 315 shares or 2.23% in the most recent quarter. The Hedge Fund company now holds 13,811 shares of NEOG which is valued at $747,866. Neogen Corporation makes up approx 0.02% of Capstone Asset Management Co’s portfolio.Legal General Group Plc boosted its stake in NEOG in the latest quarter, The investment management firm added 26,769 additional shares and now holds a total of 34,836 shares of Neogen Corporation which is valued at $1,886,369.First Mercantile Trust Co reduced its stake in NEOG by selling 1,883 shares or 10.73% in the most recent quarter. The Hedge Fund company now holds 15,672 shares of NEOG which is valued at $864,311. Neogen Corporation makes up approx 0.12% of First Mercantile Trust Co’s portfolio.

Neogen Corporation closed down -0.88 points or -1.65% at $52.56 with 81,206 shares getting traded on Friday. Post opening the session at $53.57, the shares hit an intraday low of $52.42 and an intraday high of $53.6 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Neogen Corporation reported $0.26 EPS for the quarter, missing the analyst consensus estimate by $ -0.01 based on the information available during the earnings call on Sep 27, 2016. Analyst had a consensus of $0.27. The company had revenue of $83.65 million for the quarter, compared to analysts expectations of $86.10 million. The company’s revenue was up 11.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.25 EPS.

Neogen Corporation develops manufactures and markets a diverse line of products dedicated to food and animal safety. The Company has two segments: Food Safety and Animal Safety. The Food Safety segment is engaged in the development production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins foodborne bacteria allergens and levels of general sanitation. The Animal Safety segment is engaged in the development production and marketing of products dedicated to animal safety including a complete line of consumable products marketed to veterinarians and animal health product distributors. It also provides genomic identification and related interpretive bioinformatics services. Additionally the Animal Safety segment produces and markets rodenticides disinfectants and insecticides to assist in control of rodents insects and disease in and around agricultural food production and other facilities.

Leave a Reply

Neogen Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Neogen Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.